API | Peptide Development Services | AmbioPharm

The Importance of Process Development

October 31, 2023

AmbioPharm Provides an Update on Shanghai Campus Expansion and Resumption of Customer Visits

April 25, 2023

cancer peptides icon including cancer cell dividing (in red)

Peptides for the Treatment and Prevention of Cancer

February 3, 2023

Progress Update on AmbioPharm US-Based Microwave Peptide Synthesis Capabilities

August 3, 2022

Amytrx and AmbioPharm logos

Amytrx Therapeutics Partners With AmbioPharm to Expand the Potential of Its Breakthrough Leukocyte-Targeting Anti-Inflammatory Human Peptides

July 26, 2022

Microwave-assisted SPPS: From discovery to commercial production

January 18, 2022

CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production

CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production

September 14, 2021

AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics

July 20, 2021

SETTING A NEW STANDARD

For Peptide API Manufacturing and Services

Have a Peptide project?

SUBMIT YOUR REQUIREMENTS